Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01911390 · ClinicalTrials.gov registry record · NA
Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children
A NA study of Hyperlipidemias, sponsored by Poudre Valley Health System.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 2
- Study locations
NCT01911390: Completed NA study of Hyperlipidemias, sponsored by Poudre Valley Health System.
NCT01911390 is a NA study of Hyperlipidemias that has completed, run by Poudre Valley Health System. The registered enrollment target is 41 participants, below the 4,019-participant average among 21 other Hyperlipidemias trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01911390, a NA study of Hyperlipidemias, has completed, sponsored by Poudre Valley Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 2
- Study locations
Study Summary
A multidisciplinary team of clinicians and researchers will conduct a pilot feasibility study to evaluate whether dietary intake of dry bean powder or rice bran or a combination is a helpful dietary recommendation to reduce total cholesterol levels in children with identified, modifiable CVD risk factors, elevated total cholesterol and obesity. Consumption of dry bean powder and rice bran merit additional investigation to study feasibility and acceptability in children and how they influence their lipid levels or obesity.
Primary Outcome
The primary outcome variable to be studied is total cholesterol. A full lipid panel report will also provide information on LDL, HDL, triglycerides etc.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Bean powder
- DIETARY_SUPPLEMENT Rice bran
- DIETARY_SUPPLEMENT Control arm
- DIETARY_SUPPLEMENT Bean powder and rice bran
Study Locations (2)
Colorado
- Colorado State University - Fort Collins
- Medical Center of the Rockies - Loveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT01911390 record still lists
NCT01911390 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 4,019-participant average among 21 other Hyperlipidemias trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hyperlipidemias appearing as the primary indexed condition, and to 4 interventions - of which Bean powder is the first listed.
NCT01911390 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01911390 about?
NCT01911390 is a clinical study titled "Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children". A multidisciplinary team of clinicians and researchers will conduct a pilot feasibility study to evaluate whether dietary intake of dry bean powder or rice bran or a combination is a helpful dietary recommendation to reduce total cholesterol levels in children with identified, modifiable CVD risk fa...
What is the current status of trial NCT01911390?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2013-07. Estimated completion is 2016-11.
What conditions does trial NCT01911390 study?
This clinical trial studies the following conditions: Hyperlipidemias.
What interventions are being tested in trial NCT01911390?
The interventions under investigation include: Bean powder (DIETARY_SUPPLEMENT), Rice bran (DIETARY_SUPPLEMENT), Control arm (DIETARY_SUPPLEMENT), Bean powder and rice bran (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01911390?
This trial is sponsored by Poudre Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01911390 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperlipidemias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01911390's enrollment target sits among peer trials
41 14th of 21 higher than 8 of 21 other Hyperlipidemias trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperlipidemias trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Penn Medicine Healthy Heart
RECRUITING · NA
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
RECRUITING · NA
-
Social Needs Screening and Chronic Diseases Study (WE CARE)
RECRUITING · NA
-
Centralized Prescribing for Statins
ACTIVE NOT RECRUITING · NA
-
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia